A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis - Contacts and Locations

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

This study has been completed.

Study NCT00669916. Last updated on November 21, 2008. Information provided by Novartis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00669916

Locations


United States, California
	Novartis Investigator Site
	Santa Monica, California, United States, 90211

United States, Kentucky
	Novartis Investigator Site
	Louisville, Kentucky, United States, 40217

United States, New York
	Novartis Investigator Site
	Rochester, New York, United States
	Novartis Investigator Site
	Stonybrook, New York, United States, 11790

United States, North Carolina
	Novartis Investigator Site
	High Point, North Carolina, United States, 27262

United States, Pennsylvania
	Novartis Investigator Site
	Duncansville, Pennsylvania, United States, 16635

United States, Tennessee
	Novartis Investigator Site
	Nashville, Tennessee, United States, 37215
	Novartis Investigator Site
	Goodlettsville, Tennessee, United States, 37072

United States, Washington
	Novartis Investigator Site
	Seattle, Washington, United States, 98101

Sponsors and Collaborators

Novartis

Investigators


Principal Investigator:	Novartis	Novartis investigator site